ASSETMARK, INC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$571,471
+34.1%
11,011
+54.9%
0.00%0.0%
Q2 2023$426,256
+873.1%
7,109
+702.4%
0.00%
Q1 2023$43,804
+26.2%
886
+45.7%
0.00%
Q4 2022$34,699
+131.3%
608
+95.5%
0.00%
Q3 2022$15,000
+87.5%
311
+42.0%
0.00%
Q2 2022$8,000
+166.7%
219
+133.0%
0.00%
Q1 2022$3,000940.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders